Polaris Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.24 Cr
as on 16-11-2024
- Satisfied Charges ₹ 7.50 M
as on 16-11-2024
- Revenue 6.75%
(FY 2023)
- Profit -2.86%
(FY 2023)
- Ebitda 128.75%
(FY 2023)
- Net Worth 46.17%
(FY 2023)
- Total Assets 0.51%
(FY 2023)
About Polaris Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.24 Cr. The company has closed loans amounting to ₹7.50 M, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Jayasree and Sajeev Jayasree serve as directors at the Company.
- CIN/LLPIN
U85195KL2012PTC032181
- Company No.
032181
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Polaris Diagnostics?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Jayasree  | Director | 18-Sep-2012 | Current |
| Sajeev Jayasree | Director | 05-Aug-2017 | Current |
Financial Performance of Polaris Diagnostics.
Polaris Diagnostics Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.75% increase. The company also saw a slight decrease in profitability, with a 2.86% decrease in profit. The company's net worth Soared by an impressive increase of 46.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Polaris Diagnostics?
In 2023, Polaris Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharathi Scans And Labs Private LimitedActive 8 years 11 monthsRajeev Jayasree and Sajeev Jayasree are mutual person
- Venad Pharma And Surgicals Private LimitedActive 8 years 8 months
Rajeev Jayasree is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jan 2024 | ₹1.24 Cr | Open |
Others Creation Date: 19 Jan 2021 | ₹7.50 M | Satisfied |
How Many Employees Work at Polaris Diagnostics?
Unlock and access historical data on people associated with Polaris Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Polaris Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Polaris Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
